| 000 | 01076 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517200605.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2471-254X | ||
| 024 | 7 |
_a10.1002/hep4.1043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCanini, Laetitia | |
| 245 | 0 | 0 |
_aPharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. _h[electronic resource] |
| 260 |
_bHepatology communications _c06 2017 |
||
| 300 |
_a288-292 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aKoh, Christopher | |
| 700 | 1 | _aCotler, Scott J | |
| 700 | 1 | _aUprichard, Susan L | |
| 700 | 1 | _aWinters, Mark A | |
| 700 | 1 | _aHan, Ma Ai Thanda | |
| 700 | 1 | _aKleiner, David E | |
| 700 | 1 | _aIdilman, Ramazan | |
| 700 | 1 | _aYurdaydin, Cihan | |
| 700 | 1 | _aGlenn, Jeffrey S | |
| 700 | 1 | _aHeller, Theo | |
| 700 | 1 | _aDahari, Harel | |
| 773 | 0 |
_tHepatology communications _gvol. 1 _gno. 4 _gp. 288-292 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep4.1043 _zAvailable from publisher's website |
| 999 |
_c28047869 _d28047869 |
||